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Summary and Cedar 1991; Laird and Jaenisch 1994) and in the
process of mutagenesis (Cooper and Krawczak 1989;
A wide spectrum of mutations, ranging from point mu- Magewu and Jones 1994; Tornaletti and Pfeifer 1995;
tations to large deletions, have been described in the Andrews et al. 1996). The presence of DNAmethylation
retinoblastoma gene (RB1). Mutations have been found at speciﬁc transcription-factor binding motifs within
throughout the gene; however, these genetic alterations gene regulatory regions is correlated with gene silencing
do not appear to be homogeneously distributed. In par- and contributes to temporal and tissue-speciﬁc patterns
ticular, a signiﬁcant proportion of disease-causing muta- of gene expression (Holler et al. 1988; Iguchi-Ariga and
tions result in the premature termination of protein syn- Schaffner 1989; Comb and Goodman 1990). In con-
thesis, and the majority of these mutations occur as CrT trast, methylation within gene coding regions generally
transitions at CpG dinucleotides (CpGs). Such recurrent is not associated with the regulation of gene expression.
CpG mutations, including those found in RB1, are likely Rather, DNA methylation of exonic CpGs is potentially
the result of the deamination of 5-methylcytosine within a major contributor of point mutations leading to hu-
these CpGs. In the present study, we used the sodium- man genetic disease. One-third of germ-line point muta-
bisulﬁte conversion method to detect cytosine methyla- tions leading to human genetic diseases occur at CpGs;
tion in representative exons of RB1. We analyzed DNA most of these mutations are CrT transitions (Cooper
from a variety of tissues and speciﬁcally targeted CGA and Youssouﬁan 1988; Magewu and Jones 1994; Tor-
codons in RB1, where recurrent premature termination naletti and Pfeifer 1995). This is because 5-methylcyto-
mutations have been reported. We found that DNA sine (m5C) is highly mutable by deamination, resulting
methylation within RB1 exons 8, 14, 25, and 27 ap- in transitional mutations (i.e., CrT) at CpGs. In view
peared to be restricted to CpGs, including six CGA co- of the symmetry of these CpGmotifs, the methylcytosine
dons. Other codons containing methylated cytosines on the opposite strand also may be affected, leading to
have not been reported to be mutated. Therefore, dis- GrA changes. As a consequence, CpGs are hot spots for
ease-causing mutations at CpGs in RB1 appear to be mutations, in a variety of genes (Cooper and Krawczak
determined by several factors, including the constitutive 1989; Tasheva and Roufa 1993; Ory et al. 1994; Torna-
presence of DNA methylation at cytosines within CpGs, letti and Pfeifer 1995; Rodenhiser et al. 1996, 1997).
the speciﬁc codon within which the methylated cytosine Retinoblastoma is a childhood tumor of the eye that
is located, and the particular region of the gene within results from mutations inactivating both alleles of RB1.
which that codon resides. A wide spectrum of mutations, ranging from point mu-
tations to large deletions, have been described in this
gene (Canning and Dryja 1989; Cowell et al. 1994; Loh-Introduction
mann et al. 1996; Van Orsouw et al. 1996). These muta-
The methylation of mammalian DNA occurs at cytosine tions have been found throughout the gene; however,
residues within CpG dinucleotides (CpGs). CpGs are such genetic alterations do not appear to be homoge-
distributed unevenly in the genome, and there is consid- neously distributed. In retinoblastoma tumors, the most
erable evidence for the involvement of CpG methylation common point mutation found in RB1 is a CrT transi-
in the regulation of gene expression (Bird 1987; Razin tion, most of which occur at CGA (arginine) codons and
result in premature termination. In fact, in hereditary
cases of retinoblastoma, 10%–15% of all mutations
occur at the CGA codons found in exons 8 and 17Received January 28, 1997; accepted for publication April 21, 1997.
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selective methylation of particular codons could account
for the mutability of CGA codons in particular regions
of RB1. We analyzed tissue- and allele-speciﬁc DNA
methylation in RB1, using the sodium-bisulﬁte conver-
sion method (Clark et al. 1994; Andrews et al. 1996),
and we established a precise map of DNA methylation
at all cytosine residues in four exons (8, 14, 25, and 27).
This includes the sites of recurrent mutations in exon 8
(codons 251 and 255) and in exon 14 (codon 445). We
determined that, in all four exons examined, methyla-
tion was restricted to CpGs and included cytosines that
were involved in recurrent mutations, as well as those Figure 1 RB1 exons evaluated in this study. CpGs and sites of
that were not reported to be mutated. We did not iden- recurrent mutation (indicated by an asterisk [*]), in the RB1 coding
tify any site-speciﬁc methylation that could account for region, are depicted. Inset, Representation of changes to codon identi-
ties, as a result of CrT transition mutations.differences in the occurrence or retention of mutations
at CpGs. Our data suggest that methylation is an im-
portant contributor to, but not the only factor responsi-
ble for, transition mutations in RB1. TGATGG-3, and reverse, 5-AATATTTTACTACTA-
CAAAAAAATTAACAC-3; exon 14—forward, 5-
TGAGTTTAGGAGTGTGAAGGTTAGTTTGGG-3,Material and Methods
and reverse, 5-AACCAAAATAATCTTAATACCTTA-
DNA Isolation and Modiﬁcation ACCTCC-3; exon 25—forward, 5-TTTTGATAT-
Total genomic DNA was isolated (Sambrook et al. ATTTTAAATTATAATTTGAGG-3, and reverse, 5-
1989) from normal human-tissue samples (muscle, pla- CAAAAACAATACTAAAACTCTAAATTCCCC-3;
cental, and retinal) and from tumor-tissue samples and exon 27—forward, 5-ATTAGTTTGATATGA-
(breast carcinoma), as well as from cultured ﬁbroblasts. GTATAATATATATGG-3, and reverse, 5-CTAACA-
Lymphocyte DNA was isolated from healthy blood do- TTTCAAATAACTTAAAAATCACCC-3. These prim-
nors. To determine the methylation status of cytosines ers ampliﬁed RB1 exon fragments of 348 bp, 306 bp,
within RB1, DNA was modiﬁed by use of the sodium- 309 bp, and 350 bp, which included all or most of
bisulﬁte protocol (Frommer et al. 1992; Clark et al. each of these RB1 exons. PCR was performed in 25-ml
1994; Andrews et al. 1996; Rodenhiser et al. 1996). In reactions containing 50–150 ng bisulﬁte-treated geno-
brief, 10 mg of genomic DNA was digested with EcoRI mic DNA. The ampliﬁcation conditions were 5 cycles
at 37C for 6 h and subsequently was denatured with at 94C (1 min), 60C (2 min), and 72C (3 min), fol-
1 M fresh NaOH (ﬁnal concentration of 0.3 M) at lowed by 30 cycles at 94C (1 min), 60C (2 min), and
37C for 15 min. The denatured template was treated 72C (1 min). The PCR reactions were ‘‘hot started’’ by
with 3.6 M NaHSO3 (pH 5) and 100 mM hydroqui- adding 1 ml of the reverse primer to each of the individ-
none (to a ﬁnal concentration of 3.1 M and 0.5 mM, ual samples, during an initial 94C incubation period.
respectively) and was incubated under mineral oil, at A ﬁnal 16 min soak (at 72C) also was performed.
55C for 16 h. This incubation included 5-min soak
Cloning of PCR Productperiods at 94C every 3 h, to ensure that the template
PCR product was cloned into the PCRII-TA cloningremained denatured (Tasheva and Roufa 1993; Clark
vector (TA Cloning Kit, Invitrogen). Individual positiveet al. 1994). Following this treatment, the template
clones were identiﬁed, and plasmid DNAwas isolated bywas desalted with the Wizard DNA-Cleanup System
alkaline lysis (Sambrook et al. 1989) and was sequenced(Promega) and was treated with 1 M NaOH (at 37C
with the T7 sequencing system (Pharmacia) by use offor 15 min) to remove the remaining sodium bisulﬁte.
the forward primer (Andrews et al. 1996). For eachThe DNA was precipitated with 6 M ammonium ace-
exon, a minimum of four different types of tissue weretate (pH 7) and with 2 volumes of 95% ethanol; then
examined, and at least 10 clones were sequenced forthe pellet was washed in 75% ethanol and was dis-
each type of tissue, to determine the methylation statussolved in 50 ml double-distilled H2O.
of all cytosine residues within the region analyzed. CpG-
PCR dinucleotide motifs were found to be present at codons
251, 255, and 262 (exon 8); at codons 445, 451, andIn the subsequent PCR ampliﬁcations, the following
speciﬁc primers were constructed, to amplify the sense 455 (exon 14); at codons 855, 857, and 876 (exon 25);
and at codons 908 and 910 (exon 27) (ﬁg. 1). For eachstrand of the bisulﬁte-converted genomic DNA: exon
8—forward, 5-GTTAGAATATTTTATTATTTTATA- type of tissue, bisulﬁte-converted template was com-
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pared with unconverted genomic DNA, to allow the exceptions. Methylation at sites other than a CpG was
observed rarely. The methylation status of CpNpG tri-methylation status of all cytosines to be determined. The
nucleotides also was assessed, in view of the capacitymethylation status of each of these CpGs was deter-
of the methylating machinery in mammals to modifymined for every clone in all tissue samples. Unmethyl-
CpNpG sites through maintenance and de novo methyl-ated cytosines were characterized as those bands that
ation pathways (Clark et al. 1995). However, no cyto-were absent in the C lane but that were present in the
sines within CpNpG motifs in these RB1 exons wereT lane, of the reactions from the converted template.
found to be methylated.Any bands remaining in the C lane of the sequenced
Cumulative data of methylation status for all cyto-converted DNA would indicate methylated cytosines,
sines contained within each of these RB1 exons is pre-which subsequently were ampliﬁed as cytosines (Clark et
sented in table 1. First, in exon 8 of RB1, we evaluatedal. 1994; Andrews et al. 1996; Rodenhiser et al. 1996).
the methylation status of three CpGs and of 48 non-
CpG cytosines, for each clone sequenced (ﬁg. 2). In total,Results
we analyzed 162 CpGs and 2,592 non-CpGs, within
In the present study, we used a bisulﬁte sequencing ﬁve different tissue types (breast carcinoma, ﬁbroblast,
method to evaluate DNA methylation at cytosines lymphocyte, muscle, and retinal). By comparing the T
within CpGs in RB1. In this method, the difference be- and C lanes of the converted DNA sequences with those
tween cytosines and m5C is identiﬁed by differences in of the genomic DNA sequences, we found that 93%
their reactivity to sodium bisulﬁte. This highly speciﬁc of the CpGs contained within the exon 8 clones were
chemical reaction permits the methylation status to be methylated. None of the non-CpG cytosines were found
determined for each cytosine residue on individual DNA to be methylated.
strands that have been ampliﬁed from the target tem- Similar results were found for exon 14 of RB1 (ﬁg.
plate. Total genomic DNA is denatured and then treated 3). For each clone, we analyzed 3 CpGs and 43 non-
with sodium bisulﬁte, causing the deamination of cyto- CpG cytosines. We found that most (95%) of the 123
sines and creating uracil residues. Any m5Cs remain CpGs analyzed were methylated, in each of the four
unreacted. PCR ampliﬁcation of the treated genomic types of tissue (ﬁbroblast, lymphocyte, muscle, and reti-
DNA yields a fragment of interest in which all the uracil nal) analyzed. The remaining 1,763 non-CpGs were
(formally the unmethylated cytosine) residues are ampli- consistently unmethylated. Furthermore, the region un-
ﬁed as thymine, whereas only the m5C residues are am- der investigation also included a portion of intron 14,
pliﬁed as cytosines. The ampliﬁed, converted DNA frag- which contained four additional CpGs. These cytosines
ments then can be cloned and sequenced, and the also were found to be consistently methylated (ú95%).
methylation status of all the CpGs within the DNA frag- In exon 27 (ﬁg. 4), two CpGs are present. Of the 110
ment can be established. The results can be used to eval- CpGs analyzed for this exon, 94% were found to be
uate tissue-speciﬁc or allele-speciﬁc DNA methylation methylated, in the ﬁve types of tissue (ﬁbroblast, lym-
at mutational hot spots. phocyte, muscle, placental, and retinal) examined. All
We found that all CpGs within exons 8, 14, 25, and 3,850 non-CpG cytosines were determined to be un-
methylated.27 of RB1 were consistently methylated, with a few
Table 1
Frequency of Methylated CpGs in RB1
EXON 8 EXON 14 EXON 25 EXON 27
[n Å 54] [n Å 41] [n Å 82] [n Å 55]
CGA CGA CGG CGA CGC CGA GCG CGT CGC CGA CGA
Position 251 255 262 445 451 455 855 857 876 908 910
No. (%) of
methylated
CpGs 48 (89%) 52 (96%) 51 (94%) 38 (93%) 40 (98%) 39 (95%) 59 (72%) 55 (67%) 72 (88%) 51 (93%) 52 (95%)
NOTE.—Cumulative data of methylation status of cytosines and CpGs in RB1 exons 8, 14, 25, and 27. PCR product was ampliﬁed from the bisulﬁte-converted
DNA and was cloned into the PCRII-TA cloning vector, and individual positive clones were identiﬁed and were sequenced. The DNA analyzed was from the
following tissues: retinal (exons 8, 14, 25, and 27), ﬁbroblast (exons 8, 14, 25, and 27), lymphocyte (exons 8, 14, 25, and 27), breast carcinoma (exon 8), muscle
(exons 8, 14, 25, and 27), and placental (exons 25 and 27). The number and frequency of methylated CpGs and non-CpG cytosines are presented for each CpG
within each exon. DNA methylation appeared to be consistent throughout RB1 exons 8, 14, and 27 (ú90%). However, within exon 25, DNA methylation was
less prevalent, with the rates of methylation averaging 76%. Within muscle tissue in particular, only 50% (21/42) of the CpGs analyzed in exon 25 were found to
be methylated.
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Figure 3 Results of DNA sequencing of cloned PCR product
Figure 2 Bisulﬁte-converted template compared with uncon- from exon 14 of RB1, following sodium-bisulﬁte conversion. The PCR
verted genomic DNA, to allow for the determination of the methyla- primer pair used in this experiment ampliﬁed a 306-bp fragment that
tion status of all cytosines. Unmethylated cytosines are characterized included exon 14 of RB1 and an intronic sequence ﬂanking this exon.
as those bands that were absent in the C lane but that were present The locations of CpGs are indicated on the converted sequence. The
in the T lane, of the reactions from the converted template. Bands occurrence of DNA methylation at these CpGs is indicated (‘‘m5’’).
remaining in the C lane of the sequenced converted DNA indicate The CpGs identiﬁed in this ﬁgure occur within codons 445, 451, and
methylated cytosines, which subsequently were ampliﬁed as cytosines. 455 of RB1. DNA methylation was restricted to the cytosines in these
Results of DNA sequencing of genomic DNA (left) and of cloned CpGs and was found in all tissues analyzed. DNA methylation also
PCR product from exon 8 of RB1 (right), following sodium-bisulﬁte was detected at ﬁve CpGs within intron 14, showing that methylation
conversion, are shown. The PCR primer pair used in this experiment extends throughout the RB1 region.
ampliﬁed a 348-bp fragment that included exon 8 of RB1. The loca-
tions of CpGs are indicated in the genomic sequence and in the con-
verted sequence. The occurrence of DNA methylation at these CpGs
is indicated (‘‘m5’’). The CpGs identiﬁed in this ﬁgure occur within
codons 251, 255, and 262 of RB1. DNA methylation was restricted
to the cytosines in these CpGs and was found in all tissues analyzed.
In exon 25 (ﬁg. 5), we found that the methylation
status of the three cytosines at CpGs within each clone
was signiﬁcantly more variable than in the other three
exons. We assessed methylation in a total of 246 CpGs
and 4,264 non-CpG cytosines, within ﬁve different types
of tissue (ﬁbroblast, placental, muscle, retinal, and lym-
phocyte). The most consistently methylated CpG of the
three was found in codon 876, which was methylated
88% of the time. The other two CpGs, in codons 855
and 857, were methylated an average of 72% and 67%
of the time, respectively. It was apparent that the rate
of methylation dropped signiﬁcantly for exon 25, as
compared with that for the other exons, most notably
those in the muscle clones. In contrast to the data pre-
viously collected for the exons of RB1 and of other genes Figure 4 DNA sequencing of cloned PCR product from exon
27 of RB1, following sodium-bisulﬁte conversion. The PCR primer(NF1 [Tornaletti and Pfeifer 1995], p53 [Andrews et al.
pair used in this experiment ampliﬁed a 350-bp fragment that included1996], and BRCA1 [Rodenhiser et al. 1996]) in which
exon 27 of RB1. The locations of CpGs are indicated on the convertedexonic CpGs are predominantly methylated, we have
sequence. The occurrence of DNA methylation at these CpGs is indi-
demonstrated that, in muscle clones, for exon 25 only cated (‘‘m5’’). The CpGs identiﬁed in this ﬁgure occur within codonsÇ50% of the CpGs were methylated. More speciﬁcally, 908 and 910 of RB1. DNA methylation was restricted to the cytosines
in these CpGs and was found in all tissues analyzed.codons 876, 855, and 857 were methylated in muscle
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RB1. They demonstrated an overrepresentation (Ç19-
fold) of transitions at CpGs, in RB1 germ-line muta-
tions, and determined that 69% of the single-base substi-
tutions found in 119 patients occurred at CGA codons
and led to premature terminations. This group of re-
searchers reported that no mutations were found at the
CGA codon in exon 1 of RB1. Since this codon is found
within the unmethylated CpG island, it was suggested
that it is precisely this absence of methylation that corre-
lates to the lack of mutations found in this exon (Greger
et al. 1989; Lohmann et al. 1996).
We determined that the methylation status of exonic
CpGs in RB1 indeed may contribute to the hypermuta-
bility of these sites. We have established a precise map
of DNA methylation at all cytosine residues in four ex-
ons (8, 14, 25, and 27) of RB1. This includes the sites
of recurrent mutations in exon 8 (codons 251 and 255)
and in exon 14 (codon 445) (Cowell et al. 1994; Blan-
quet et al. 1995; Lohmann et al. 1996). By also analyzingFigure 5 DNA sequencing of cloned PCR product from exon
25 of RB1, following sodium-bisulﬁte conversion. The PCR primer the methylation status of cytosines found within exons
pair used in this experiment ampliﬁed a 309-bp fragment that included 25–27, we attempted to determine whether the lack of
exon 25 of RB1. The locations of CpGs are indicated on the converted mutations associated with this region can be attributed
sequence. The occurrence of DNA methylation at these CpGs is indi-
to an absence of methylation within these exons. Wecated (‘‘m5’’). The CpGs identiﬁed in this ﬁgure occur within codons
observed that exonic CpGs in RB1 appear to be consis-855, 857, and 876 of RB1. DNA methylation was restricted to the
cytosines in these CpGs and was found in all tissues analyzed. How- tently methylated, including those CpGs at which muta-
ever, methylation at these sites was less consistent than that in other tions have not been described. In at least one exon (exon
tissues. 14), methylation also was apparent at the intronic CpGs
that were examined.
We also determined that all the examined CpGs that
only 36%, 43%, and 71% of the time, respectively. are associated with recurrent mutations are found
Although the rates of methylation in this particular tis- within CGA codons. Both exons 8 and 14 contain three
sue were comparatively low for all the exons analyzed, CpGs (ﬁg. 1). For each exon, two of these CpGs are
this general phenomenon of relative hypomethylation located within CGA codons, and the remaining CpGs
seems to have been restricted to exon 25. are located within CGG and CGC codons. However,
only those cytosines found within the CGA codons are
associated with recurrent mutations in retinoblastomaDiscussion
patients. It would appear that, although the majority of
exonic CpGs are consistently methylated, not all of theseApproximately 35% of mutations associated with hu-
man genetic diseases are known to occur at CpGs (Coo- cytosines are associated with mutations and that the
hypermutability of CpGs cannot be attributed to methyl-per and Youssouﬁan 1988; Magewu and Jones 1994;
Tornaletti and Pfeifer 1995). The hypermutability of ation status alone. The mutability of particular cytosines
also seems to be dependent on the particular amino acidthese sites is thought to be related to the methylation
status of the cytosines found in CG motifs and is attrib- changes resulting from CrT or GrA transition muta-
tions. In the case of RB1, such changes at CGA codonsuted to the spontaneous deamination of m5C (Cooper
and Krawczak 1989; Laird and Jaenisch 1994). Given are particularly signiﬁcant, since these transitions lead
to the formation of TGA codons, resulting in prematurethat CpGs are underrepresented Ç5-fold and that m5C
represents õ1% of all nucleotides, in the mammalian termination of the protein product.
Similar observations have been made by Tornalettigenome (Laird and Jaenisch 1994), the proportion of
mutations attributed to CpGs is quite signiﬁcant. In fact, and Pfeifer (1995), who evaluated the contribution of
methylation to mutagenesis in the p53 tumor-suppressorthe incidence of transition mutations is thought to be
20 1 higher at CpGs than at non-CpG sites (Tornaletti gene. In p53, ﬁve of six mutational hot spots are found
at CpGs, and each of these cytosines were methylatedand Pfeifer 1995). Lohmann et al. (1996) recently identi-
ﬁed recurrent mutations at most of the 14 CGA codons in all the tissues that were examined. These data for the
p53 gene, as well as data from previous work from ourin RB1, with the exception of exons 25–27, despite the
presence of two CGA codons within this 3 region of own lab, on DNA methylation within the NF1 and
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BRCA1 genes (Andrews et al. 1996; Rodenhiser et al. lated in a cell-cycle–speciﬁc manner, much like phos-
phorylation differentiates between active and inactive1996, 1997), lead us to conclude that the occurrence
of mutational hot spots is not the result of selective forms of the RB1 protein product. Further studies are
required to determine whether cell-stage–speciﬁc meth-methylation at a subset of CpGs. Rather, other factors
modulate the mutagenicity of methylated CpGs in the ylation indeed does occur.
Our group and others have established that CpGscoding regions of these tumor-suppressor genes. These
factors may cause regional differences in the degree of in the coding regions of many genes are consistently
methylated (Tornaletti and Pfeifer 1995; Andrews et al.methylation at speciﬁc regions of the coding sequence,
such as those we have observed in exon 25 of RB1. 1996; Rodenhiser et al. 1996). In view of the propensity
of methylated cytosines to be deaminated, leading toTherefore, at least two features contribute to muta-
tions at CpGs in RB1—(1) the constitutive presence of the formation of mutations, as well as the expense of
maintaining the methylating machinery, what is the pos-DNA methylation at cytosines within CpGs and (2) the
speciﬁc codon within which that methylated cytosine is sible beneﬁt of coding-region methylation to the mam-
malian genome? Certainly the functional importance oflocated (Ory et al. 1994; Tornaletti and Pfeifer 1995).
We feel that it is particularly relevant that these recur- methylation must outweigh its apparent deleterious ef-
fects. DNA methylation is thought to play a role bothrent mutations at CGA codons in RB1, p53, and NF1
lead to premature-termination mutations, and we sug- in the regulation of gene expression and in the mainte-
nance of the structural integrity and organization ofgest that the clinical disease phenotype selects for muta-
tions at this codon. These mutations no doubt have a chromatin (Antequera et al. 1990). Several studies have
suggested a role for methylation in maintaining a hetero-profound effect on the expression of these tumor-sup-
pressor genes, since the inactivation of such genes likely chromatinized state. Methylation may play a role in the
formation of an inactive chromatin structure, which in-confers a proliferative advantage resulting from the re-
lease of growth constraints normally enforced by these hibits access to transcription factors and/or particular
nucleases, such as DNase I and MspI. This inactivatedgenes. Therefore, it may be beneﬁcial for the individual
cell to maintain such mutations in order to outcompete state is thought to involve the binding of proteins speciﬁc
to methylated DNA. One group of proteins, known assurrounding cells, despite the obvious detriment to the
whole organism. In this way, any individual tumor cell ‘‘methyl-CpG binding proteins’’ (‘‘MeCP 1’’ and
‘‘MeCP 2’’), have been demonstrated to be associatedthat has been able to restore at least one RB1 allele,
by the removal or prevention of methylation, would be with centromeric heterochromatin (Nan et al. 1996;
Tate et al. 1996). Another group of proteins, the methyl-overtaken nonetheless by those cells that lack any re-
strictions on proliferation (Sakai et al. 1991; Greger et ated DNA binding proteins, have been shown to possess
some sequence homology with histone H1. Several stud-al. 1994).
Limited differences in the speciﬁcity of methylation ies suggest that histone H1 preferentially binds to CpG-
methylated DNA (McArthur and Thomas 1996).found within the various regions of RB1 also are appar-
ent. The relative hypomethylation demonstrated within Methylation also may serve as a protective measure to
preserve the integrity of the mammalian genome, againstall the tissues analyzed for exon 25, as compared with
the incidence of methylation found in exons 8, 14, and foreign (viral) invasion or against attack by nucleases
(Barlow 1993; Keshet et al. 1986). In the promoter re-27, may suggest that this is why no methylation-medi-
ated mutations have been associated with the exon 25 gions of genes, hypomethylation permits the transcrip-
tion of genes, through increased access of transcriptionregion of RB1. However, exon 27 (also devoid of known
mutations) has been shown to possess rates of methyla- factors to their requisite DNA-sequence elements. How-
ever, this same lack of methylation, when present withintion comparable to that of the other two exons (8 and
14) analyzed, within which recurrent mutations have gene-coding regions, has been associated with genomic
instability, leading to deletion mutations. These eventsbeen reported. Lohmann et al. (1996) have suggested
that mutations at the 3-terminal region of RB1 may may occur when hypomethylation leads to an increased
accessibility of sequences to DNA-damaging agentsnot be oncogenic. A distinguishing feature of exon 25,
however, is that it contains a nuclear-localization signal (such as DNAse I) (Keshet et al. 1986), as well as an
increased accessibility to oxidants and/or enzyme-in-(NLS), to direct the protein product of RB1 (p110RB1)
through the nuclear membrane into the nucleus (Zack- duced DNA-strand breakage (Leteurtre et al. 1994; Po-
gribny et al. 1995). Furthermore, hypomethylation maysenhaus et al. 1993). The 3 end of this consensus se-
quence for the NLS motif contains an arginine codon decrease binding sites for methyl-speciﬁc binding pro-
teins (Pogribny et al. 1995) or may alter DNA-histone(CGC at position 876), which was one of the CpGs
under analysis in this study and which was found to be interactions. In fact, deletions have been detected in the
regions surrounding exon 25 of RB1 (i.e., in exons 23consistently methylated. It is possible that this NLS is
controlled partially by methylation status and is regu- and 24 and in intron 24) (Hogg et al. 1993; Henson et
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and breast-carcinoma tissue, from Dr. F. O’Malley. D.M. is aal. 1994; Kato et al. 1994; Lohmann et al. 1994). Fur-
recipient of a Natural Sciences and Engineering Researchther work is required to determine whether the apparent
Council Post Graduate Scholarship.relative decrease in constitutive methylation that we
have described, in this region of RB1, is related to spe-
ciﬁc deletion events in RB1.
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